jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 12, 2005

Dec. 17, 2018

jRCT1080220086

Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndrome

version:
date:

Ono Pharmaceutical Co., Ltd.

06-6263-5670

Interventional

Open study

4

Male and female patients with ALI associated with SIRS aged over 18 years old are included.

18age old over
No limit

Both

Acute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS)

investigational material(s)
Generic name etc : Sivelestat sodium hydrate
INN of investigational material :
Therapeutic category code : 399 Agents affecting metabolism, n.e.c.
Dosage and Administration for Investigational material : Injection

Efficacy and safety

ONO PHARMACEUTICAL CO.,LTD.

JapicCTI-050088

History of Changes

No Publication date
9 Dec. 17, 2018 (this page) Changes
8 Dec. 28, 2015 Detail Changes
7 Dec. 28, 2015 Detail Changes
6 June. 25, 2010 Detail Changes
5 June. 25, 2010 Detail Changes
4 June. 18, 2008 Detail Changes
3 June. 18, 2008 Detail Changes
2 Sept. 12, 2005 Detail Changes
1 Sept. 12, 2005 Detail